Antihistamines are among the most commonly purchased over-the-counter medications worldwide, used primarily for allergic rhinitis (hay fever), urticaria (hives), and other allergic conditions. Understanding the differences between generations helps you choose the right one for your needs.

Histamine is released from mast cells during allergic reactions and binds to H1 receptors, causing the classic symptoms: sneezing, itchy/watery eyes, runny nose, and hives. H1 antihistamines compete with histamine for these receptors, blocking the allergic response. They don't stop histamine release — they prevent it from acting.

Diphenhydramine (Benadryl), chlorpheniramine, clemastine, and hydroxyzine cross the blood-brain barrier readily, causing significant sedation, cognitive impairment, and anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation). They have a short duration of action (4–6 hours), requiring multiple daily doses. Despite these drawbacks, they remain useful for acute allergic reactions and as nighttime sleep aids. They are generally NOT recommended for chronic allergy management.

Cetirizine, loratadine, fexofenadine, desloratadine, and bilastine were designed to minimize CNS penetration. They cause significantly less drowsiness (though cetirizine is mildly sedating in some patients), last 24 hours, and have minimal anticholinergic effects. They are the preferred choice for chronic allergic rhinitis and urticaria.

Fexofenadine is the least sedating of the second-generation antihistamines and does not interact with grapefruit juice (unlike some competitors). Cetirizine is the fastest-acting (onset within 1 hour) and may be slightly more potent, but causes drowsiness in ~10% of users. Loratadine is truly non-sedating for most people but has the slowest onset (2–3 hours). For nighttime use with insomnia, diphenhydramine's sedative effect can be beneficial — but tolerance develops rapidly.

Intranasal antihistamines (azelastine) and corticosteroid sprays (fluticasone, mometasone) are often more effective than oral antihistamines for nasal congestion. Antihistamine eye drops (olopatadine) provide targeted relief for allergic conjunctivitis.

First-generation antihistamines impair driving ability comparable to alcohol intoxication. They should be avoided in the elderly (fall risk, cognitive impairment) and in patients with glaucoma, urinary retention, or BPH. Do not combine antihistamines with alcohol, sedatives, or other CNS depressants. If allergy symptoms are not controlled with second-generation antihistamines, consult an allergist for further evaluation.